EP4089113 - Bibliographic data

POLYPEPTIDES

Last update 23/07/2025
Legal status Brevet déchu
Origin Européen

(73) Holder

Sorriso Pharmaceuticals, Inc.

9295 S. 1300 E. No.3
Sandy , UT 84094
États-Unis d'Amérique
(72) Inventors

Scott CROWE

Cambridge, CB22 3GN
Royaume-Uni

Mike WEST

Cambridge, CB22 3GN
Royaume-Uni

Kevin ROBERTS

Cambridge, CB22 3GN
Royaume-Uni

Tim CARLTON

Cambridge, CB22 3GN
Royaume-Uni

Luana MAGGIORE

Cambridge, CB22 3GN
Royaume-Uni

Marion CUBITT

Cambridge, CB22 3GN
Royaume-Uni

Keith RAY

Cambridge, CB22 3GN
Royaume-Uni
(74) Agent

Mail recipient

Sagittarius IP

Marlow International Parkway
Marlow SL7 1YL
Royaume-Uni

(21) Request number EP22155238.3
(22) Request date 31/03/2016

(11) Publication number EP4089113
Publication date 13/12/2023

(54) Title of the invention POLYPEPTIDES
(51) International classification C07K 16/24A61K 9/00A61K 9/19A61K 31/606A61K 31/7088A61K 31/713A61K 38/00A61K 45/06A61P 1/04A61P 1/16A61P 3/10A61P 17/00A61P 17/06A61P 29/00A61P 37/04A61P 43/00A61K 39/00A61P 37/02
International classification (before reform) None

Claimed priority

(31) Number: 15162112
(32) Date: 31/03/2015
(33) Country: EP

Initial application None
Divisional application None

Expected annuity Annuity: 9 - Amount: 175 € - Due date 02/04/2024
Surtax: 9 - Amount: 35 € - Due date 03/10/2024
Last annuity None

Publication None
History

Publication de la délivrance du brevet européen - Legal date 13/12/2023


Entrée en période de grâce du brevet d'invention - Legal date 03/04/2024


Déchéance du brevet d'invention après période de grâce - Legal date 02/04/2024